The International Society of Glomerular Disease (ISGD) is hosting The Clinical Trials Summit, an inaugural global forum for clinical trialists, nephrologists and other stakeholders working to advance research in kidney disease. The Summit will take place November 13-15, 2026 in Galveston, Texas, and focus on accelerating innovation, fostering collaboration, and addressing key challenges in clinical trials in glomerular disease and beyond.
Travere at ISGD 2026
Travere is proud to participate in ISGD’s inaugural Clinical Trials Summit, where we will engage with nephrology experts and present work to advance research and care for people living with rare kidney disease.
Program
Saturday, Nov 14
Sparsentan vs Irbesartan in Hispanic and Latino Patients With Focal Segmental Glomerulosclerosis (FSGS) in the Phase 3 DUPLEX Trial
Authors: German T Hernandez, Ana Paredes, Priscila Preciado, Rob Geletka, Kristie Kusibab, Herman Trimarchi
Session: Poster Sessions & Networking
Type: Poster
Time: 4:15 PM to 5:00 PM
Meet a Travere MSL
Connect with a Travere Medical Science Liaison (MSL) for peer-to-peer scientific exchange, grounded in our clinical data and the evolving landscape of IgAN and FSGS.
Schedule a meetingSparsentan vs Irbesartan in Patients With Focal Segmental Glomerulosclerosis (FSGS) Without Nephrotic Syndrome in the Phase 3 DUPLEX Trial
Authors: German T Hernandez, Jai Radhakrishnan, Julie Lin, Radko Komers, Edward Murphy, Kenneth V Lieberman
Session: Poster Sessions & Networking
Type: Poster
Time: 4:15 PM to 5:00 PM
Incident Patients With IgA Nephropathy (IgAN) Demonstrated Stable eGFR With First-Line Sparsentan Over 2 Years in the SPARTAN
Authors: Chris Gisler, Stephanie Moody, Neeraj Dhaun, Siân V Griffin, Radko Komers, Alex Mercer, Smeeta Sinha, Justyna Szklarzewicz, Matthew Sayer, Lisa Willcocks, Jonathan Barratt, Chee Kay Cheung
Session: Poster Sessions & Networking
Type: Poster
Time: 4:15 PM to 5:00 PM
In DUPLEX, Patients With Focal Segmental Glomerulosclerosis (FSGS) Reached Low Proteinuria More Often With Sparsentan vs Irbesartan Regardless of Baseline Proteinuria
Authors: German T Hernandez, Kenneth Lieberman, Jula Inrig, Radko Komers, Kristi Kusibab, Jai Radhakrishnan
Session: Poster Sessions & Networking
Type: Poster
Time: 4:15 PM to 5:00 PM
MA-SP-26-0177| November 2026